>_ QFI Terminal
TerminalStocks › WGRX

Wellgistics Health, Inc. (WGRX) Stock

Healthcare · Medical - Distribution · US
$3.60 +32.66%
Last updated Sep 20, 2026 13:07 UTC

WGRX Key Statistics

Market Cap$255.01M
P/E (TTM)-2.46
P/S (TTM)10.93
P/B (TTM)-20.50
Revenue (TTM)$23.34M
EPS (TTM)$-1.46
Dividend Yield
ROE (TTM)9,999.99%
Net Margin-433.95%
Gross Margin-41.30%
52W High$11.55
52W Low$0.10
Analyst View
Price Target
Employees31
Volume424,576

About Wellgistics Health, Inc.

Wellgistics Health, Inc. operates as a wholesaler and distributor of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company distributes generic and branded pharmaceuticals, as well as over-the-counter healthcare and consumer products. It also offers third-party logistics services that include warehousing, inventory management, pick and pack, and shipping to small and mid-size pharmaceutical manufacturers. It also operates DelivMeds platform that serves as a pharmaceutical hub to facilitate the transfer of prescriptions and provide backend clinical concierge services to a network of independent pharmacies; and operates a retail community specialty. The company was formerly known as Danam Health, Inc. and changed its name to Wellgistics Health, Inc. in October 2024. Wellgistics Health, Inc. was incorporated in 2022 and is based in Tampa, Florida.

CEO: Prashant Patel. Company website

WGRX — Frequently Asked Questions

What is the WGRX stock price today?

Wellgistics Health, Inc. (WGRX) trades at $3.60, up 32.66% on the day, as of Sep 20, 2026 13:07 UTC.

What is Wellgistics Health, Inc.'s market cap?

Wellgistics Health, Inc. has a market capitalisation of $255.01M, calculated from the live WGRX share price and shares outstanding.

What is the P/E ratio of WGRX?

WGRX has no meaningful price-to-earnings ratio: Wellgistics Health, Inc. lost $1.46 per share over the last twelve months, and a P/E is only defined on positive earnings.

How much revenue does Wellgistics Health, Inc. make?

Wellgistics Health, Inc. generated revenue of $23.34M over the trailing twelve months, which puts the stock at 10.93 times sales.

What is the 52-week range for WGRX?

WGRX has traded between $0.10 and $11.55 over the past 52 weeks, and the last price is 68.9% below that high.

Is Wellgistics Health, Inc. profitable?

No. Wellgistics Health, Inc. is loss-making, with a net margin of -433.95% over the trailing twelve months.

What sector is Wellgistics Health, Inc. in?

Wellgistics Health, Inc. is classified under the Healthcare sector and the Medical - Distribution industry, and is domiciled in US .

Who is the CEO of Wellgistics Health, Inc.?

Prashant Patel is the chief executive of Wellgistics Health, Inc., which employs 31 people.

Where can I track WGRX in real time?

QFI Terminal shows WGRX with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.

See WGRX live in QFI Terminal

Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.

Open WGRX in Terminal See plans

Medical - Distribution stocks

MCK McKesson Corporation COR Cencora, Inc. CAH Cardinal Health, Inc. HSIC Henry Schein, Inc. OMI Owens & Minor, Inc. RDGT Ridgetech Inc. SNYR Synergy CHC Corp. MEHA Functional Brands, Inc. Common Stock

More Healthcare stocks

UNH UnitedHealth Group Incorporated CVS CVS Health Corp. MCK McKesson Corporation COR Cencora, Inc. NVO Novo Nordisk A/S CI Cigna Corporation CAH Cardinal Health, Inc. ELV Elevance Health Inc.